February 14, 2022
Investors in SCWorx Corp. have reached a $3.3 million settlement with the health care logistics company to resolve claims that it misled investors when it announced a major COVID-19 test kit contract in the early days of the pandemic.
November 19, 2020
Hospital contractor SCWorx and its chief executive told a Manhattan federal judge on Wednesday that a proposed class of investors failed to show that the company had lied in connection with a COVID-19 test supply deal that purportedly fell apart in the spring.
September 18, 2020
Kaplan Fox & Kilsheimer LLP will represent a proposed class of investors in a suit alleging hospital contractor SCWorx "overstated or entirely fabricated" its announcement in April that it would soon earn millions weekly by supplying COVID-19 rapid testing kits.
June 30, 2020
Four legal teams are competing to represent a proposed class of investors in Manhattan federal court suit accusing health care analytics company SCWorx Corp. of securities fraud after the firm landed on a list of public companies subject to U.S. Securities and Exchange Commission trading suspensions linked to claims about combating coronavirus.
May 29, 2020
At least 50 federal securities cases with references to COVID-19 have been filed in the past three months, including merger challenges, regulatory enforcement actions and sprawling investor suits, according to a Law360 review of filings. As the pandemic pushes into the summer, Law360 is taking a look at eight major investor actions that were brought in connection with the novel coronavirus since March.
April 30, 2020
Investors slapped a health care supplier with a proposed securities fraud class action on Wednesday, claiming it misled them by boasting it was poised to sell millions of COVID-19 rapid testing kits in a deal that turned out to be backed by alleged fraudsters and convicted felons.